PSY155 - DETERMINING THE VALUE OF EMICIZUMAB (HEMLIBRA®) FOR THE PROPHYLAXIS TREATMENT OF HAEMOPHILIA A PATIENTS WITH INHIBITORS IN SPAIN BY MULTI-CRITERIA DECISION ANALYSIS (MCDA)
Álvarez, M.T., Cuervo-Arango, I., Perez-Santamarina, R., Poveda, J., Romero, J.A., Santamaría, A., Trillo, J.L., Tort, M., Badia, X.
Published in Value in health (01.10.2018)
Published in Value in health (01.10.2018)
Get full text
Journal Article
PRO104 DETERMINING THE VALUE OF EMICIZUMAB FOR THE PROPHYLAXIS OF SEVERE HAEMOPHILIA A PATIENTS WITHOUT INHIBITORS IN SPAIN BY MULTI-CRITERIA DECISION ANALYSIS (MCDA)
Álvarez, E., Álvarez, M.T., Cuervo-Arango, I., Núñez, R., Perez-Santamarina, R., Poveda, J.L., Romero, J.A., Queralt, M., Pablo, Q., Luís, V., Tort, M., Badia, F.J.
Published in Value in health (01.11.2019)
Published in Value in health (01.11.2019)
Get full text
Journal Article